Neurocrine Biosciences Stock Forecast

Stock Price Forecast

The 22 analysts with 12-month price forecasts for Neurocrine Biosciences stock have an average target of 175.23, with a low estimate of 140 and a high estimate of 204. The average target predicts an increase of 31.32% from the current stock price of 133.44.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$140	$175.23	$177	$204
Change	+4.92%	+31.32%	+32.64%	+52.88%

Analyst Ratings

The average analyst rating for Neurocrine Biosciences stock from 22 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	9	10	10	12	12	11
Buy	8	8	8	8	6	8
Hold	1	1	1	2	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	18	19	19	22	21	22

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Rudy Li Wolfe Research	Wolfe Research	Buy Initiates $160	Buy	Initiates	$160	+19.90%	Feb 24, 2026
Anupam Rama JP Morgan	JP Morgan	Buy Maintains $177 → $176	Buy	Maintains	$177 → $176	+31.89%	Feb 17, 2026
Danielle Brill Truist Securities	Truist Securities	Strong Buy Maintains $169 → $140	Strong Buy	Maintains	$169 → $140	+4.92%	Feb 17, 2026
Mohit Bansal Wells Fargo	Wells Fargo	Buy Maintains $180 → $175	Buy	Maintains	$180 → $175	+31.15%	Feb 13, 2026
Yigal Nochomovitz Citigroup	Citigroup	Strong Buy Maintains $203 → $204	Strong Buy	Maintains	$203 → $204	+52.88%	Feb 12, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

3.51B

from 2.86B

22.85%

from 2.86B

Revenue Next Year

3.87B

from 3.51B

9.99%

from 3.51B

EPS This Year

6.11

from 4.67

30.84%

from 4.67

EPS Next Year

8.29

from 6.11

35.71%

from 6.11

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	1.13B	1.49B	1.89B	2.36B	2.86B	3.51B	3.87B
Revenue Growth	8.38%	31.34%	26.76%	24.81%	21.45%	22.85%	9.99%
EPS	0.92	1.56	2.47	3.29	4.67	6.11	8.29
EPS Growth	-77.89%	69.57%	58.33%	33.20%	41.95%	30.84%	35.71%
Forward PE	-	-	-	-	-	21.84	16.09
No. Analysts	-	-	-	-	-	31	29

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	3.8B	5.0B
Avg	3.5B	3.9B
Low	3.2B	3.3B

Revenue Growth

Revenue Growth	2026	2027
High	33.2%	42.0%
Avg	22.8%	10.0%
Low	13.0%	-4.7%

EPS Forecast

EPS	2026	2027
High	7.57	14.81
Avg	6.11	8.29
Low	4.26	4.58

EPS Growth

EPS Growth	2026	2027
High	62.1%	142.3%
Avg	30.8%	35.7%
Low	-8.7%	-25.1%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.